Longview Acquisition Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company intends to focus on businesses in the healthcare, industrials, consumer, media, technology, and technology services sector. The company was incorporated in 2020 and is based in New York, New York.
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that would have taken the cardiac test company public. Hear...
Heartflow Holding Inc (NYSE: HFLO) aims to bring its noninvasive, artificial intelligence (AI)-based test for coronary heart disease to more doctors and patients via a SPAC merger with Longview Ac...
Glenview Capital is leading a SPAC to take Heartflow public in $2.8B deal. Larry Robbins, Glenview Capital founder and CEO and Longview acquisition II chairman, and Dr. John Stevens, Heartflow co-foun...